Skip to main content
. 2015 Apr 20;35(5):558–566. doi: 10.1038/onc.2015.114

Table 2. IC50 values for EI1, EPZ-6438 and compound 3 against PRC2WT, PRC2Y111L, PRC2Y641N and PRC2Y641N/Y661D.

Inhibitor Substrate WT (μM) Y111L (μM) Y641N (μM) Y641N/Y6661D (μM)
EI1 Me0 0.2±0.03 >25 (−) (−)
  Me1 0.06±0.0 >25 0.1±0.03 >25
  Me2 (−) (−) 0.2±0.05 >25
EPZ-6438 Me0 0.2±0.04 11.5±4.3 (−) (−)
  Me1 0.06±0.01 9.2±2.7 0.1±0.03 2.8±1.1
  Me2 (−) (−) 0.1±0.04 3.4±0.8
Compound 3 Me0 2.02±0.4 >25 (−) (−)
  Me1 0.9±0.2 >25 6.1±0.8 >25
  Me2 (−) (−) 8.7±1.1 >25

Abbreviation: WT, wild type.

The biochemical reaction was carried out with [SAM] at 20 μM. The assay was carried out with [SAM] of 20 μM. When indicated with (-), those conditions were not tested due to low basal activity.